Log in

NASDAQ:NBIXNeurocrine Biosciences SEC Filings & 10K Form

$124.80
+3.63 (+3.00 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$120.14
Now: $124.80
$124.89
50-Day Range
$85.09
MA: $101.58
$124.41
52-Week Range
$72.14
Now: $124.80
$127.28
Volume639,800 shs
Average Volume839,134 shs
Market Capitalization$11.59 billion
P/E Ratio67.83
Dividend YieldN/A
Beta1.26

SEC Filings

Neurocrine Biosciences (NASDAQ:NBIX) SEC Filings

DateFilerForm TypeView
05/21/2020
6:00 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:59 PM
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:57 PM
Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:55 PM
MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:52 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:42 PM
Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:09 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2020
6:15 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:59 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
7:09 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
7:17 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
7:06 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
3:27 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:46 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:44 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:43 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:42 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:41 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:40 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:38 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:35 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:33 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:32 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2020
8:48 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
3:36 PM
Neurocrine Biosciences (Filer)
Form DEFA14A
04/09/2020
3:30 PM
Neurocrine Biosciences (Filer)
Form DEF 14A
04/09/2020
3:11 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
7:02 AM
Neurocrine Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2020
6:23 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:21 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:17 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:16 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:14 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:13 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:10 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:09 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:08 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:06 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
6:32 AM
BlackRock Inc. (Filed by)
Neurocrine Biosciences (Subject)
Form SC 13G/A
02/07/2020
5:54 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:50 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:49 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:47 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:46 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:44 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:40 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:38 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:37 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:35 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:16 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
3:10 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:14 PM
Neurocrine Biosciences (Filed by)
Xenon Pharmaceuticals Inc. (Subject)
Form SC 13D
12/10/2019
8:43 AM
FMR LLC (Filed by)
Neurocrine Biosciences (Subject)
Form SC 13G/A
12/04/2019
5:06 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
4:37 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:41 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:36 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:10 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
3:20 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2019
5:15 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
2:12 PM
Neurocrine Biosciences (Filer)
Form CT ORDER
09/12/2019
3:06 PM
Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
3:05 PM
Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2019
3:46 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
6:52 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:44 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
6:39 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
6:15 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
6:14 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
6:12 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
6:11 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
3:23 PM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2019
3:07 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
6:08 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
6:06 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:15 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
4:56 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:47 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:26 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
5:18 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
4:45 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
5:27 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:53 PM
Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:46 PM
Neurocrine Biosciences (Issuer)
Sandrock Alfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:44 PM
MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:37 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:35 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:34 PM
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
3:15 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
5:36 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
5:33 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/15/2019
6:24 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:23 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
3:30 PM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2019
3:18 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
12:45 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
3:15 PM
Neurocrine Biosciences (Filer)
Form DEF 14A
03/14/2019
3:34 PM
Neurocrine Biosciences (Reporting)
Voyager Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:31 PM
Neurocrine Biosciences (Reporting)
Voyager Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2019
12:48 PM
Neurocrine Biosciences (Subject)
Form SC 13G/A
This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.